Our latest #clinical trial, which compares the effectiveness of #yoga vs. #strength training in knee #osteoarthritis, has been published in #JAMAOpen. It will be my last trial as a PI as Iam on a career break to travel the world. https://t.co/4c4CdHty2N
I am thrilled to share that this literature review was published as a Book Chapter in Elsevier's book titled: Cartilage Tissue and Knee Joint Biomechanics.
🔗https://t.co/BXtcgK7WvO
#AcademicPublishing#BookChapter
CAMs were commonly used among Tasmanian older adults, with 35% using them alone or with conventional #analgesics for #jointpain. CAM users were more likely to be female, better educated, have more joints with #OA , and have healthier lifestyles
https://t.co/SXHNf87ylF
A new study found that the quantitative (cartilage volume & thickness, subchondral bone area) and semi-quantitative (BMLs & cartilage defect) #MRI markers can be explored as a marker of clinical progression of #OA in a young adult population.
📖 https://t.co/cmvDUGkX6J
👀 👇
Our recent paper explored if serum inflammatory markers and synovitis assessed by contrast-enhanced magnetic resonance imaging (CE-MRI) of the knee can explain the pain reduction we observed in our CurKOA clinical trial (869). https://t.co/G0qekbn0qd
@IRACON_2022 @IndianRheum Received this email 📩and the certificate 🗞️
Glad 😀that our paper was awarded the Best Overseas paper award 🥇at the IRACON 2022.
Thanks, @IRACON_2022 and @IndianRheum, for this opportunity and appreciation.
#PhDchat@drbennysamuel
Our latest #metaanalyses indicate a lack of benefit of #colchicine in reducing symptoms in hand/knee OA patients. We still believe that future trials should focus on the subgroups of OA patients with local or systemic inflammation and/or mineralization. https://t.co/L4vixJbOWp
This 2018 study found that 80% of the “most transformative” medicines approved for clinical use by the FDA could be traced back to one or several basic discoveries, which occurred on average three decades before approval! https://t.co/bdQlvdsPeg
We often neglect the drugs based on modest effects that fail to meet MCID in #OA#clinicaltrials. Modelled data from #OAI shows that even 1 point (out of 20) WOMAC pain reduction leads to prevention of #kneereplacement under dynamic intervention strategies.https://t.co/UMXYbIfP50
#Realworld effectiveness and safety outcomes among biologic and synthetic #DMARDs found similar discontinuation rates and Clinical Disease Activity Index response: results from 19 registers from the ‘JAK-pot’ collaboration https://t.co/l1CotDvg4w
Modest but significant overall effect. Interesting to see a large effect by baseline CRP (≥3 mg/L), in line with #CANTOS trial results. Krill oil improved osteoarthritic knee pain in adults with mild to moderate knee osteoarthritis. https://t.co/f5j1mA1aOO
#VITAL trial shows vit D did not prevent fracture. Final nail in the coffin? adding to the pool of results on cancer, CVD, falls, atrial fibrillation, body composition, migraine, stroke, knee pain painpainhttps://www.nejm.org/doi/full/10.1056/NEJMoa2202106#.YuHRTQrRzz4.twitter
OARSI Peer Review Mentoring Program
Aim: to increase the pool of qualified reviewers and improve the quality of reviews for the OARSI journals.
This initiative is organized by the ECI Committee, in collaboration with the OAC and OACO editors.
https://t.co/B8MYhRdATb
📢Our new #GBDStudy study reporting - Burden of osteoarthritis in India and its states, 1990–2019 published @OACJournal found the burden and impact of OA in India to be substantial and increasing.
@drbennysamuel@IHME_UW
https://t.co/h73clvWKFq
This trial is an example of the importance of conducting clinical trials in the primary care settings before making recommendations based on randomised placebo-controlled trials alone.
https://t.co/R7MbVPpti9